Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM).
Epistemonikos ID: f5b0582bdf145e1a43fef0f49f11ab78dac66ba6
First added on: May 12, 2024